Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver
Max Preti, Lena Schlott, David Lübbering, Daria Krzikalla, Anna-Lena Müller, Fenja A. Schuran, Tobias Poch, Miriam Schakat, Sören Weidemann, Ansgar W. Lohse, Christina Weiler-Normann, Marcial Sebode, Dorothee Schwinge, Christoph Schramm, Antonella Carambia, Johannes Herkel
Max Preti, Lena Schlott, David Lübbering, Daria Krzikalla, Anna-Lena Müller, Fenja A. Schuran, Tobias Poch, Miriam Schakat, Sören Weidemann, Ansgar W. Lohse, Christina Weiler-Normann, Marcial Sebode, Dorothee Schwinge, Christoph Schramm, Antonella Carambia, Johannes Herkel
View: Text | PDF
Research Article Hepatology

Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver

  • Text
  • PDF
Abstract

The liver is an immune-privileged organ that can deactivate autoreactive T cells. Yet in autoimmune hepatitis (AIH), autoreactive T cells can defy hepatic control and attack the liver. To elucidate how tolerance to self-antigens is lost during AIH pathogenesis, we generated a spontaneous mouse model of AIH, based on recognition of an MHC class II–restricted model peptide in hepatocytes by autoreactive CD4+ T cells. We found that the hepatic peptide was not expressed in the thymus, leading to deficient thymic deletion and resulting in peripheral abundance of autoreactive CD4+ T cells. In the liver, autoreactive CD4+ effector T cells accumulated within portal ectopic lymphoid structures and maturated toward pathogenic IFN-γ and TNF coproducing cells. Expansion and pathogenic maturation of autoreactive effector T cells was enabled by a selective increase of plasticity and instability of autoantigen-specific Tregs but not of nonspecific Tregs. Indeed, antigen-specific Tregs were reduced in frequency and manifested increased IL-17 production, reduced epigenetic demethylation, and reduced expression of Foxp3. As a consequence, autoantigen-specific Tregs had a reduced suppressive capacity, as compared with that of nonspecific Tregs. In conclusion, loss of tolerance and the pathogenesis of AIH were enabled by combined failure of thymic deletion and peripheral regulation.

Authors

Max Preti, Lena Schlott, David Lübbering, Daria Krzikalla, Anna-Lena Müller, Fenja A. Schuran, Tobias Poch, Miriam Schakat, Sören Weidemann, Ansgar W. Lohse, Christina Weiler-Normann, Marcial Sebode, Dorothee Schwinge, Christoph Schramm, Antonella Carambia, Johannes Herkel

×

Figure 7

Functional characterization of Tregs in Alb-iGP_Smarta mice.

Options: View larger image (or click on image) Download as PowerPoint
Functional characterization of Tregs in Alb-iGP_Smarta mice.
(A) Selecti...
(A) Selectively reduced Foxp3 MFI in tetramer-specific vs. nonspecific CD4+ Foxp3+ Tregs in livers and spleens of Alb-iGP_Smarta mice (n = 4). (B) Reduced CNS2 element demethylation at the Foxp3 gene locus in tetramer-specific vs. nonspecific splenic CD4+ Foxp3+ Tregs purified and pooled from 10 Alb-iGP_Smarta mice. (C) Age-dependent decline of tetramer-specific vs. nonspecific CD4+ Foxp3+ Tregs (n = 5–7). (D) No age-dependent change in overall Foxp3+ Treg frequency among CD4+ T cells (n = 5–7). (E) Selectively reduced percentage of CD39-expressing cells, and (F) selectively increased percentage of IL-17 producers among tetramer-specific vs. nonspecific CD4+Foxp3+ Tregs in livers and spleens of Alb-iGP_Smarta mice (n = 4). (G) Selectively reduced suppressive function of tetramer-specific (blue) vs. nonspecific (red) splenic CD4+Foxp3+ Tregs of Alb-iGP_Smarta mice (n = 5). Data are shown as the mean ± SEM. *P < 0.05; **P < 0.01; ****P < 0.0001 (A, C, and D, Mann-Whitney; E, ANOVA).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts